Results 191 to 200 of about 37,867 (235)
Some of the next articles are maybe not open access.
Safety of virus inactivated antithrombin III concentrate ANTITHROMBIN III IMMUNO (AT III)
Thrombosis Research, 1992In a prospective clinical trial the risk of infection after application of virus inactivated antithrombin III concentrate ANTITHROMBIN III IMMUNO (AT III) was investigated in patients undergoing cardiovascular surgery. The study was conducted according to the recommendations of the International Committee on Thrombosis and Hemostasis (ICTH), with the ...
D U, Preiss +3 more
openaire +2 more sources
Thrombin-Antithrombin III Complexes and Antithrombin III in Amniotic Fluid
Gynecologic and Obstetric Investigation, 1997We measured thrombin-antithrombin III (TAT) complexes and antithrombin III (AT III) in amniotic fluid and blood plasma of 39 parturient women. TAT was measured by ELISA. Partigen plates were used for measuring the antigen of AT III, and activity was determined using chromogenic substrate.
M, Uszyński +3 more
openaire +2 more sources
Neonatal antithrombin III deficiency
The American Journal of Medicine, 1989Hemorrhagic and thrombotic complications are common in sick preterm infants and may reflect inadequate regulation of coagulation. All neonates have low levels of the pivotal regulator antithrombin III (ATIII) compared with adults. Plasma levels of ATIII are very low in preterm infants and are further diminished in infants with respiratory distress ...
openaire +2 more sources
Sneddon's Syndrome and Antithrombin III
The Journal of Dermatology, 1999AbstractSneddon's syndrome, an uncommon disorder, is characterized by multiple cerebrovascular accidents along with ideopathic livedo reticularis. In this article, two cases who had increased amounts of antithrombin III and were diagnosed with Sneddon's syndrome are presented.
Bolayir E. +4 more
openaire +4 more sources
Antithrombin III and Atherosclerosis
1984The mechanisms leading to the initiation of atherosclerosis are very complex. Since Duguid’s modification of Rokitansky’s theory, atherosclerosis has been related to thrombogenesis. Several investigators proposed the clumping of platelets to play a crucial role in the initiation of atheroma formation.
J, Conard, M, Castel, M, Samama
openaire +2 more sources
Biological Antithrombin III Levels
JAMA: The Journal of the American Medical Association, 1978To the Editor.— The MEDICAL NEWS article "Automated Test Measures Functional Antithrombin, Coagulation Enzymes" (report of Jayed Fareed, PhD, and Harry L. Mesmore, MD) confirms my observations 1 and those of others 2,3 that there is poor correlation between immunological (total) and functional antithrombin III levels in disease states.
openaire +2 more sources
The pregnant antithrombin III deficient patient: Management without antithrombin III concentrate
Thrombosis Research, 1992Pregnant patients with antithrombin III (AT III) deficiency have an unacceptably high risk of venous thromboembolism (VTE). Antithrombotic therapy is therefore recommended. The reported clinical experience of such prophylaxis is limited. Some authors have recommended the use of AT III concentrate in addition to heparin in the management of these ...
E, Blondel-Hill, M J, Mant
openaire +2 more sources
Antithrombin III replacement in animal models of acquired antithrombin III deficiency
Blood Coagulation & Fibrinolysis, 1994Plasma antithrombin III (AT III) levels decrease early during Gram-negative septicaemia, and even a moderate decrease in this major inhibitor of the coagulation system is associated with serious disseminated intravascular coagulation (DIC). This study reports the efficacy of high dose (at least 250 units/kg) AT III replacement in three animal models of
openaire +2 more sources